EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals

Mariangela Palazzo, Francesca Gorini iD, Ludovica Simonini iD, Fabrizio Minichilli iD, Andrea Borghini iD

Genes · 21.06.2026 · 17 (6) · 717

DOI: 10.3390/genes17060717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 21.06.2026. Verfasst von Mariangela Palazzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Endocrine Disruptors, Gene-Environment Interaction, Oxidative Stress. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Environmental exposure to persistent and non-persistent endocrine-disrupting chemicals (EDCs), including per- and polyfluoroalkyl substances (PFAS), polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), polycyclic aromatic hydrocarbons (PAHs), dioxins, phthalates, and bisphenols, has been increasingly associated with elevated cardiovascular disease (CVD) risk. Emerging evidence suggests the importance of gene–environment interactions in modulating individual susceptibility to EDC-related cardiovascular effects. This review summarizes current knowledge by synthesizing the main classes of EDCs, evaluating the evidence linking them to cardiovascular outcomes, and highlighting how genetic variability may modulate EDC-induced cardiovascular risk. Across the studies analyzed, the most extensively investigated genetic polymorphisms involve pathways related to oxidative stress regulation, xenobiotic metabolism and detoxification, hormone signaling, and lipid homeostasis. Variants in antioxidant defense genes, such as CAT, eNOS, and PON1, have been associated with increased hypertension risk and vascular dysfunction following exposure to bisphenols and PAHs. Polymorphisms in GSTP1, CYP2C19, CYP1A2, CYP2E1, ABCB1, and MTHFR may influence susceptibility to cardiometabolic alterations and congenital heart defects, whereas variants in ESR2, FTO, LEPR, and INSIG2 have been linked to obesity, dyslipidemia, and hypertension associated with PFAS, PBDEs, and bisphenols. A deeper understanding of gene–environment interactions is essential to advance preventive cardiology and mitigate the cardiovascular impact of environmental pollutants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesEndocrine DisruptorsGene-Environment InteractionOxidative StressHumansPolymorphism, GeneticRiskGenes

Stichwörter der Autor:innen

PAHsPBDEsPCBsPFASbisphenolscardiovascular riskdioxinsendocrine-disrupting chemicalsgenetic polymorphismsphthalates

Substanzen

Endocrine Disruptors

Autor:innen und Institutionen

  • Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

ORCID-Profile: Francesca Gorini, Ludovica Simonini, Fabrizio Minichilli, Andrea Borghini

Zitieren

APA

Palazzo, M., Gorini, F., Simonini, L., Minichilli, F., & Borghini, A. (2026). Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals. Genes, 17(6), 717. https://doi.org/10.3390/genes17060717

Vancouver

Palazzo M, Gorini F, Simonini L, Minichilli F, Borghini A. Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals. Genes. 2026;17(6):717. doi:10.3390/genes17060717

BibTeX
@article{Palazzo2026,
  author = {Palazzo, Mariangela and Gorini, Francesca and Simonini, Ludovica and Minichilli, Fabrizio and Borghini, Andrea},
  title = {Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {717},
  doi = {10.3390/genes17060717}
}
Kostenlos starten →